Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]

Abstract

Ohar JA, Ozol-Godfrey A, Goodin T, Sanjar S. Int J Chron Obstruct Pulmon Dis. 2020;15:995–1004. The authors have advised there is an error in Figure 4B on page 1000. For EXACT-RS responder rates, the OR for both genders are shown to be significant at p<0.05; however, the OR is significant only in males. The correct Figure 4 is shown below. The authors apologize for this error. Read the original article

Keywords

• copd
• gender
• lama
• nebulized glycopyrrolate.